X4 PHARMACEUTICALS, INC (XFOR) Free cash flow 2016–2025
X4 PHARMACEUTICALS, INC (XFOR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$85.6MFY2025 · since FY2016: -$21.7M → -$85.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$85.6M | +34.8% |
| FY2024 | -$131.2M | -35.9% |
| FY2023 | -$96.6M | -25.1% |
| FY2022 | -$77.2M | -7.9% |
| FY2021 | -$71.5M | -18.8% |
| FY2020 | -$60.2M | -24.8% |
| FY2019 | -$48.2M | -89.7% |
| FY2018 | -$25.4M | -17.2% |
| FY2017 | -$21.7M | +0.1% |
| FY2016 | -$21.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice